Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-18

Clinical Trial Update: Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating clinical equivalence between two linaclotide products for chronic idiopathic constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linaclotide (linaclotide)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Chronic Idiopathic Constipation | Phase 3 | Status: UNKNOWN